Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A rare disease.

Jos P J Wester1

  • 1Department of Intensive Care Medicine, Onze Lieve Vrouwe Gasthuis, HM Amsterdam, The Netherlands. j.p.j.wester@olvg.nl

Critical Care (London, England)
|January 17, 2007
PubMed
Summary
This summary is machine-generated.

Thrombocytopenia, a low platelet count, is common in critically ill patients. Heparin-induced thrombocytopenia is rare, but intensivists should use the International Society on Thrombosis and Haemostasis diagnostic system.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ecological effects of selective decontamination of the digestive tract (SDD) on antimicrobial resistance: a 21-year longitudinal single-centre study.

Critical care (London, England)·2019
Same author

Clinical Effects of Perioperative Selective Decontamination of the Digestive Tract (SDD) in Cardiac Surgery: A Propensity Score Matched Cohort Analysis.

Journal of cardiothoracic and vascular anesthesia·2019
Same author

Telemedicine in a Dutch intensive care unit: A descriptive study of the first results.

Journal of telemedicine and telecare·2015
Same author

Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia.

BMC anesthesiology·2015
Same author

Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot study.

European journal of anaesthesiology·2014
Same author

Citrate anticoagulation for continuous venovenous hemofiltration.

Critical care medicine·2008
Same journal

45th International Symposium on Intensive Care & Emergency Medicine.

Critical care (London, England)·2026
Same journal

High-resolution monitoring reveals fragmented 24-hour light exposure in intensive care units.

Critical care (London, England)·2026
Same journal

Coronary microvascular function in patients with sepsis and myocardial injury: an invasive coronary physiology study.

Critical care (London, England)·2026
Same journal

Comparative performance of mitral E/e' versus inferior vena cava variability for predicting fluid responsiveness in mechanically ventilated adults with shock.

Critical care (London, England)·2026
Same journal

Different lungs or different patients? Insights into postoperative ARDS.

Critical care (London, England)·2026
Same journal

Predictive validity of SOFA-2: analytical and contextual considerations.

Critical care (London, England)·2026
See all related articles

Area of Science:

  • Critical Care Medicine
  • Hematology
  • Immunology

Background:

  • Thrombocytopenia is frequently observed in critically ill patients.
  • Heparin-induced thrombocytopenia (HIT) is an uncommon cause of decreased platelet counts.
  • Accurate diagnosis of HIT is crucial for patient management.

Purpose of the Study:

  • To highlight the importance of diagnosing heparin-induced thrombocytopenia in critically ill patients.
  • To recommend the use of the International Society on Thrombosis and Haemostasis diagnostic classification system for HIT.
  • To address the clinical significance of anti-heparin/platelet factor 4 autoantibodies without overt HIT.

Main Methods:

  • Review of diagnostic criteria for heparin-induced thrombocytopenia.
  • Application of the International Society on Thrombosis and Haemostasis (ISTH) scoring system.

Related Experiment Videos

  • Discussion of serological markers in the context of clinical presentation.

    • Main Results:

    • Thrombocytopenia is a common complication in intensive care settings.
    • Heparin-induced thrombocytopenia is a rare but serious complication.
    • The ISTH diagnostic system provides a framework for evaluating suspected HIT.
    • The clinical impact of positive anti-heparin/platelet factor 4 antibodies without HIT is uncertain.

    Conclusions:

    • Intensivists must be vigilant for thrombocytopenia in critically ill patients.
    • The ISTH diagnostic classification system is recommended for diagnosing heparin-induced thrombocytopenia.
    • Further research is needed to clarify the clinical relevance of anti-heparin/platelet factor 4 autoantibodies in the absence of HIT symptoms.